APO Research
Talk to an analyst

APO RESEARCH · REPORT

Galantamine Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Galantamine Tablets Market Outlook and Growth Opportunities 2026

29 December 2025194 pages

Choose your research edition.

Industry ResearchGalantamine Tablets Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Galantamine Tablets Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Galantamine Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Galantamine Tablets Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Galantamine Tablets Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Galantamine Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Galantamine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Galantamine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Galantamine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Galantamine Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Galantamine Tablets market include Zhejiang Jinhua CONBA Bio-Pharm, YiChang HEC ChangJiang Pharmaceutical, Yabao Pharmaceutical, Sinopharm, Zydus, Sun Pharma, Sandoz, Hikma and Dr. Reddy's Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Galantamine Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Galantamine Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Galantamine Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Galantamine Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Galantamine Tablets Segment by Company

Zhejiang Jinhua CONBA Bio-Pharm

YiChang HEC ChangJiang Pharmaceutical

Yabao Pharmaceutical

Sinopharm

Zydus

Sun Pharma

Sandoz

Hikma

Dr. Reddy's Laboratories

Barr Pharmaceuticals

Aurobindo Pharma

Galantamine Tablets Segment by Type

Extended-release Tablets

Orally Disintegrating Tablets

Immediate-release Tablets

Galantamine Tablets Segment by Application

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Galantamine Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Galantamine Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Galantamine Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Galantamine Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Galantamine Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Galantamine Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Galantamine Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Galantamine Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Galantamine Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Galantamine Tablets industry.

Chapter 3: Detailed analysis of Galantamine Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Galantamine Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Galantamine Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Galantamine Tablets Industry Trends Table 2. Galantamine Tablets Industry Drivers Table 3. Galantamine Tablets Industry Opportunities and Challenges Table 4. Galantamine Tablets Industry Restraints Table 5. Global Galantamine Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Galantamine Tablets Revenue Share by Company (2021-2026) Table 7. Global Galantamine Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Galantamine Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Galantamine Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Galantamine Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Galantamine Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Galantamine Tablets Company, Product Type & Application Table 13. Global Galantamine Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Galantamine Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Extended-release Tablets Table 18. Significant Companies of Orally Disintegrating Tablets Table 19. Significant Companies of Immediate-release Tablets Table 20. Global Galantamine Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Galantamine Tablets Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Galantamine Tablets Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Galantamine Tablets Sales Volume Share by Type (2021-2026) Table 24. Global Galantamine Tablets Sales Volume Share by Type (2027-2032) Table 25. Global Galantamine Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Galantamine Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Galantamine Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Galantamine Tablets Sales Value Share by Type (2021-2026) Table 29. Global Galantamine Tablets Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Retail Pharmacy Table 31. Significant Companies of Hospital Pharmacy Table 32. Significant Companies of Online Pharmacy Table 33. Global Galantamine Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Galantamine Tablets Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Galantamine Tablets Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Galantamine Tablets Sales Volume Share by Application (2021-2026) Table 37. Global Galantamine Tablets Sales Volume Share by Application (2027-2032) Table 38. Global Galantamine Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Galantamine Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Galantamine Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Galantamine Tablets Sales Value Share by Application (2021-2026) Table 42. Global Galantamine Tablets Sales Value Share by Application (2027-2032) Table 43. Global Galantamine Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Galantamine Tablets Sales by Region (2021-2026) & (K Units) Table 45. Global Galantamine Tablets Sales Market Share by Region (2021-2026) Table 46. Global Galantamine Tablets Sales by Region (2027-2032) & (K Units) Table 47. Global Galantamine Tablets Sales Market Share by Region (2027-2032) Table 48. Global Galantamine Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Galantamine Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Galantamine Tablets Sales Value Share by Region (2021-2026) Table 51. Global Galantamine Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Galantamine Tablets Sales Value Share by Region (2027-2032) Table 53. Global Galantamine Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Galantamine Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Galantamine Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Galantamine Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Galantamine Tablets Sales by Country (2021-2026) & (K Units) Table 58. Global Galantamine Tablets Sales Market Share by Country (2021-2026) Table 59. Global Galantamine Tablets Sales by Country (2027-2032) & (K Units) Table 60. Global Galantamine Tablets Sales Market Share by Country (2027-2032) Table 61. Global Galantamine Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Galantamine Tablets Sales Value Market Share by Country (2021-2026) Table 63. Global Galantamine Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Galantamine Tablets Sales Value Market Share by Country (2027-2032) Table 65. Zhejiang Jinhua CONBA Bio-Pharm Company Information Table 66. Zhejiang Jinhua CONBA Bio-Pharm Business Overview Table 67. Zhejiang Jinhua CONBA Bio-Pharm Galantamine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Zhejiang Jinhua CONBA Bio-Pharm Galantamine Tablets Product Portfolio Table 69. Zhejiang Jinhua CONBA Bio-Pharm Recent Development Table 70. YiChang HEC ChangJiang Pharmaceutical Company Information Table 71. YiChang HEC ChangJiang Pharmaceutical Business Overview Table 72. YiChang HEC ChangJiang Pharmaceutical Galantamine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. YiChang HEC ChangJiang Pharmaceutical Galantamine Tablets Product Portfolio Table 74. YiChang HEC ChangJiang Pharmaceutical Recent Development Table 75. Yabao Pharmaceutical Company Information Table 76. Yabao Pharmaceutical Business Overview Table 77. Yabao Pharmaceutical Galantamine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Yabao Pharmaceutical Galantamine Tablets Product Portfolio Table 79. Yabao Pharmaceutical Recent Development Table 80. Sinopharm Company Information Table 81. Sinopharm Business Overview Table 82. Sinopharm Galantamine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Sinopharm Galantamine Tablets Product Portfolio Table 84. Sinopharm Recent Development Table 85. Zydus Company Information Table 86. Zydus Business Overview Table 87. Zydus Galantamine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Zydus Galantamine Tablets Product Portfolio Table 89. Zydus Recent Development Table 90. Sun Pharma Company Information Table 91. Sun Pharma Business Overview Table 92. Sun Pharma Galantamine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Sun Pharma Galantamine Tablets Product Portfolio Table 94. Sun Pharma Recent Development Table 95. Sandoz Company Information Table 96. Sandoz Business Overview Table 97. Sandoz Galantamine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Sandoz Galantamine Tablets Product Portfolio Table 99. Sandoz Recent Development Table 100. Hikma Company Information Table 101. Hikma Business Overview Table 102. Hikma Galantamine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Hikma Galantamine Tablets Product Portfolio Table 104. Hikma Recent Development Table 105. Dr. Reddy's Laboratories Company Information Table 106. Dr. Reddy's Laboratories Business Overview Table 107. Dr. Reddy's Laboratories Galantamine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Dr. Reddy's Laboratories Galantamine Tablets Product Portfolio Table 109. Dr. Reddy's Laboratories Recent Development Table 110. Barr Pharmaceuticals Company Information Table 111. Barr Pharmaceuticals Business Overview Table 112. Barr Pharmaceuticals Galantamine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Barr Pharmaceuticals Galantamine Tablets Product Portfolio Table 114. Barr Pharmaceuticals Recent Development Table 115. Aurobindo Pharma Company Information Table 116. Aurobindo Pharma Business Overview Table 117. Aurobindo Pharma Galantamine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Aurobindo Pharma Galantamine Tablets Product Portfolio Table 119. Aurobindo Pharma Recent Development Table 120. Key Raw Materials Table 121. Raw Materials Key Suppliers Table 122. Galantamine Tablets Distributors List Table 123. Galantamine Tablets Customers List Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Galantamine Tablets Product Image Figure 2. Global Galantamine Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Galantamine Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Galantamine Tablets Sales (2021-2032) & (K Units) Figure 5. Global Galantamine Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Galantamine Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Extended-release Tablets Image Figure 10. Orally Disintegrating Tablets Image Figure 11. Immediate-release Tablets Image Figure 12. Global Galantamine Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Galantamine Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Galantamine Tablets Sales Volume Share by Type (2021-2032) Figure 15. Global Galantamine Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Galantamine Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Galantamine Tablets Sales Value Share by Type (2021-2032) Figure 18. Retail Pharmacy Image Figure 19. Hospital Pharmacy Image Figure 20. Online Pharmacy Image Figure 21. Global Galantamine Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Galantamine Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Galantamine Tablets Sales Volume Share by Application (2021-2032) Figure 24. Global Galantamine Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Galantamine Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Galantamine Tablets Sales Value Share by Application (2021-2032) Figure 27. Global Galantamine Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Galantamine Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Galantamine Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Galantamine Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Galantamine Tablets Sales Value (2021-2032) & (US$ Million) Figure 32. North America Galantamine Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Galantamine Tablets Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Galantamine Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Galantamine Tablets Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Galantamine Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Galantamine Tablets Sales Value (2021-2032) & (US$ Million) Figure 38. South America Galantamine Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Galantamine Tablets Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Galantamine Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Galantamine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Galantamine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Galantamine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Galantamine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Galantamine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Galantamine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Galantamine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Galantamine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Galantamine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Galantamine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Galantamine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Galantamine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Galantamine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Galantamine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Galantamine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Galantamine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Galantamine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Galantamine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Galantamine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Galantamine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Galantamine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Galantamine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Galantamine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Galantamine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Galantamine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Galantamine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Galantamine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Galantamine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Galantamine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Galantamine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Galantamine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Galantamine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Galantamine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Galantamine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Galantamine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Galantamine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Galantamine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Galantamine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Galantamine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Galantamine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Galantamine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Galantamine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Galantamine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Galantamine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Galantamine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Galantamine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Galantamine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Galantamine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Galantamine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Galantamine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Galantamine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Galantamine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Galantamine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Galantamine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Galantamine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Galantamine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Galantamine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Galantamine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Galantamine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Galantamine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Galantamine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Galantamine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Galantamine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Galantamine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Galantamine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Galantamine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Galantamine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Galantamine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Galantamine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Galantamine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Galantamine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Galantamine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Galantamine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Galantamine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Galantamine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Galantamine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Galantamine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Galantamine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Galantamine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Galantamine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Galantamine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Galantamine Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Galantamine Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Galantamine Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Galantamine Tablets Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Galantamine Tablets Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Extended-release Tablets
  • Orally Disintegrating Tablets
  • Immediate-release Tablets
Applications
  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy
Companies covered
  • Zhejiang Jinhua CONBA Bio-Pharm
  • YiChang HEC ChangJiang Pharmaceutical
  • Yabao Pharmaceutical
  • Sinopharm
  • Zydus
  • Sun Pharma
  • Sandoz
  • Hikma
  • Dr. Reddy's Laboratories
  • Barr Pharmaceuticals
  • Aurobindo Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Galantamine Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Galantamine Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Galantamine Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Galantamine Tablets Market Dynamics
  1. 2.1 Galantamine Tablets Industry Trends
  2. 2.2 Galantamine Tablets Industry Drivers
  3. 2.3 Galantamine Tablets Industry Opportunities and Challenges
  4. 2.4 Galantamine Tablets Industry Restraints
3 Galantamine Tablets Market by Company
  1. 3.1 Global Galantamine Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Galantamine Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Galantamine Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Galantamine Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Galantamine Tablets Company Ranking (2024-2026)
  6. 3.6 Global Galantamine Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Galantamine Tablets Company Product Type and Application
  8. 3.8 Global Galantamine Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Galantamine Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Galantamine Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Galantamine Tablets Market by Type
  1. 4.1 Galantamine Tablets Type Introduction
  2. 4.1.1 Extended-release Tablets
  3. 4.1.2 Orally Disintegrating Tablets
  4. 4.1.3 Immediate-release Tablets
  5. 4.2 Global Galantamine Tablets Sales Volume by Type
  6. 4.2.1 Global Galantamine Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Galantamine Tablets Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Galantamine Tablets Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Galantamine Tablets Sales Value by Type
  10. 4.3.1 Global Galantamine Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Galantamine Tablets Sales Value by Type (2021-2032)
  12. 4.3.3 Global Galantamine Tablets Sales Value Share by Type (2021-2032)
5 Galantamine Tablets Market by Application
  1. 5.1 Galantamine Tablets Application Introduction
  2. 5.1.1 Retail Pharmacy
  3. 5.1.2 Hospital Pharmacy
  4. 5.1.3 Online Pharmacy
  5. 5.2 Global Galantamine Tablets Sales Volume by Application
  6. 5.2.1 Global Galantamine Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Galantamine Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Galantamine Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Galantamine Tablets Sales Value by Application
  10. 5.3.1 Global Galantamine Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Galantamine Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Galantamine Tablets Sales Value Share by Application (2021-2032)
6 Galantamine Tablets Regional Sales and Value Analysis
  1. 6.1 Global Galantamine Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Galantamine Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Galantamine Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Galantamine Tablets Sales by Region (2027-2032)
  5. 6.3 Global Galantamine Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Galantamine Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Galantamine Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Galantamine Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Galantamine Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Galantamine Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Galantamine Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Galantamine Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Galantamine Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Galantamine Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Galantamine Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Galantamine Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Galantamine Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Galantamine Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Galantamine Tablets Sales Value Share by Country, 2025 VS 2032
7 Galantamine Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Galantamine Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Galantamine Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Galantamine Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Galantamine Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Galantamine Tablets Sales by Country (2027-2032)
  6. 7.4 Global Galantamine Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Galantamine Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Galantamine Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Galantamine Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Galantamine Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Galantamine Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Galantamine Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Galantamine Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Galantamine Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Galantamine Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Galantamine Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Galantamine Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Galantamine Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Galantamine Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Galantamine Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Galantamine Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Galantamine Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Galantamine Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Galantamine Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Galantamine Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Galantamine Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Galantamine Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Galantamine Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Galantamine Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Galantamine Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Galantamine Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Galantamine Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Galantamine Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Galantamine Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Galantamine Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Galantamine Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Galantamine Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Galantamine Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Galantamine Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Galantamine Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Galantamine Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Galantamine Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Galantamine Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Galantamine Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Galantamine Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Galantamine Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Galantamine Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Galantamine Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Galantamine Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Galantamine Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Galantamine Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Galantamine Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Galantamine Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Galantamine Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Galantamine Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Galantamine Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Galantamine Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Galantamine Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Galantamine Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Galantamine Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Galantamine Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Galantamine Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Galantamine Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Galantamine Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Galantamine Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Galantamine Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Galantamine Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Galantamine Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Galantamine Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Galantamine Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Galantamine Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Galantamine Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Galantamine Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Galantamine Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Galantamine Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Galantamine Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Galantamine Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Galantamine Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Galantamine Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Galantamine Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Galantamine Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Galantamine Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Galantamine Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Galantamine Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Galantamine Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Galantamine Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Galantamine Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Galantamine Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Galantamine Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Galantamine Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Galantamine Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Galantamine Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Jinhua CONBA Bio-Pharm
  2. 8.1.1 Zhejiang Jinhua CONBA Bio-Pharm Company Information
  3. 8.1.2 Zhejiang Jinhua CONBA Bio-Pharm Business Overview
  4. 8.1.3 Zhejiang Jinhua CONBA Bio-Pharm Galantamine Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Jinhua CONBA Bio-Pharm Galantamine Tablets Product Portfolio
  6. 8.1.5 Zhejiang Jinhua CONBA Bio-Pharm Recent Developments
  7. 8.2 YiChang HEC ChangJiang Pharmaceutical
  8. 8.2.1 YiChang HEC ChangJiang Pharmaceutical Company Information
  9. 8.2.2 YiChang HEC ChangJiang Pharmaceutical Business Overview
  10. 8.2.3 YiChang HEC ChangJiang Pharmaceutical Galantamine Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 YiChang HEC ChangJiang Pharmaceutical Galantamine Tablets Product Portfolio
  12. 8.2.5 YiChang HEC ChangJiang Pharmaceutical Recent Developments
  13. 8.3 Yabao Pharmaceutical
  14. 8.3.1 Yabao Pharmaceutical Company Information
  15. 8.3.2 Yabao Pharmaceutical Business Overview
  16. 8.3.3 Yabao Pharmaceutical Galantamine Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Yabao Pharmaceutical Galantamine Tablets Product Portfolio
  18. 8.3.5 Yabao Pharmaceutical Recent Developments
  19. 8.4 Sinopharm
  20. 8.4.1 Sinopharm Company Information
  21. 8.4.2 Sinopharm Business Overview
  22. 8.4.3 Sinopharm Galantamine Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sinopharm Galantamine Tablets Product Portfolio
  24. 8.4.5 Sinopharm Recent Developments
  25. 8.5 Zydus
  26. 8.5.1 Zydus Company Information
  27. 8.5.2 Zydus Business Overview
  28. 8.5.3 Zydus Galantamine Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Zydus Galantamine Tablets Product Portfolio
  30. 8.5.5 Zydus Recent Developments
  31. 8.6 Sun Pharma
  32. 8.6.1 Sun Pharma Company Information
  33. 8.6.2 Sun Pharma Business Overview
  34. 8.6.3 Sun Pharma Galantamine Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Sun Pharma Galantamine Tablets Product Portfolio
  36. 8.6.5 Sun Pharma Recent Developments
  37. 8.7 Sandoz
  38. 8.7.1 Sandoz Company Information
  39. 8.7.2 Sandoz Business Overview
  40. 8.7.3 Sandoz Galantamine Tablets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Sandoz Galantamine Tablets Product Portfolio
  42. 8.7.5 Sandoz Recent Developments
  43. 8.8 Hikma
  44. 8.8.1 Hikma Company Information
  45. 8.8.2 Hikma Business Overview
  46. 8.8.3 Hikma Galantamine Tablets Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Hikma Galantamine Tablets Product Portfolio
  48. 8.8.5 Hikma Recent Developments
  49. 8.9 Dr. Reddy's Laboratories
  50. 8.9.1 Dr. Reddy's Laboratories Company Information
  51. 8.9.2 Dr. Reddy's Laboratories Business Overview
  52. 8.9.3 Dr. Reddy's Laboratories Galantamine Tablets Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Dr. Reddy's Laboratories Galantamine Tablets Product Portfolio
  54. 8.9.5 Dr. Reddy's Laboratories Recent Developments
  55. 8.10 Barr Pharmaceuticals
  56. 8.10.1 Barr Pharmaceuticals Company Information
  57. 8.10.2 Barr Pharmaceuticals Business Overview
  58. 8.10.3 Barr Pharmaceuticals Galantamine Tablets Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Barr Pharmaceuticals Galantamine Tablets Product Portfolio
  60. 8.10.5 Barr Pharmaceuticals Recent Developments
  61. 8.11 Aurobindo Pharma
  62. 8.11.1 Aurobindo Pharma Company Information
  63. 8.11.2 Aurobindo Pharma Business Overview
  64. 8.11.3 Aurobindo Pharma Galantamine Tablets Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Aurobindo Pharma Galantamine Tablets Product Portfolio
  66. 8.11.5 Aurobindo Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Galantamine Tablets Value Chain Analysis
  2. 9.1.1 Galantamine Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Galantamine Tablets Sales Mode & Process
  6. 9.2 Galantamine Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Galantamine Tablets Distributors
  9. 9.2.3 Galantamine Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst